Becton, Dickinson and Company D&A decreased by 8.3% to $563.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $567.00M to $563.00M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 2.5% CAGR.
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
depreciation_and_amortization_cf| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $535.00M | $582.00M | $546.00M | $548.00M | $554.00M | $581.00M | $567.00M | $563.00M | $571.00M | $587.00M | $561.00M | $571.00M | $568.00M | $586.00M | $607.00M | $567.00M | $659.00M | $629.00M | $614.00M | $563.00M |
| QoQ Change | — | +8.8% | -6.2% | +0.4% | +1.1% | +4.9% | -2.4% | -0.7% | +1.4% | +2.8% | -4.4% | +1.8% | -0.5% | +3.2% | +3.6% | -6.6% | +16.2% | -4.6% | -2.4% | -8.3% |
| YoY Change | — | — | — | — | +3.6% | -0.2% | +3.8% | +2.7% | +3.1% | +1.0% | -1.1% | +1.4% | -0.5% | -0.2% | +8.2% | -0.7% | +16.0% | +7.3% | +1.2% | -0.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Connected Care | — | — | $194.00M | $199.00M | — | — | $194.00M | $194.00M |
| Interventional | $196.50M | $196.50M | $200.00M | $198.00M | — | — | $197.00M | $192.00M |
| Medical Essentials | — | — | $135.00M | $136.00M | — | — | $141.00M | $147.00M |
| BioPharma Systems | — | — | $31.00M | $32.00M | — | — | $34.00M | $27.00M |
| Life Sciences | $68.00M | $68.00M | $44.00M | — | — | — | $45.00M | — |
| Medical | $304.00M | $304.00M | $348.25M | $348.25M | $348.25M | $348.25M | — | — |
| Total | $568.00M | $586.00M | $607.00M | $567.00M | $659.00M | $629.00M | $614.00M | $563.00M |
Medical is derived from annual filings.